re CHIR, parking some stuff
"In May 1997, Hyseq entered into a collaboration with Chiron
in which Hyseq's Gene Discovery program is identifying genes
related to solid tumor (cancer) formation. The focus of the
collaboration between Hyseq and Chiron is to develop therapeutics,
diagnostics and vaccines for solid tumor cancer. Hyseq will receive
milestones and royalties on such products. Chiron also has an equity
investment in Hyseq. As of December 1998, patent applications on over
6,300 gene discoveries from the collaboration have been filed,
validating the approach and commercial power of Hyseq's Gene
Discovery program."
From the Chiron website:
Gene Identification
Cancer Genome
In May 1997, Chiron established a strategic partnership with bioinformatics company Hyseq, Inc. focusing on decoding and analyzing genes involved in cancer. With more than 60,000 genetic sequences identified, Hyseq and Chiron have built one of the world's largest proprietary cancer gene databases.
The company has developed high-throughput techniques to rapidly discover new genes and analyze their patterns of expression in an effort to identify genes involved in specific disease pathways. As part of this endeavor, the company has established a collaboration in cancer genomics with Hyseq, Inc. to access its highly efficient gene sequencing technology called "Sequencing-by-Hybridization." This program has yielded thousands of novel genetic sequences that may be related to cancer and have potential as targets for novel therapies, as well as cancer diagnostic markers and vaccine components. In hepatitis C, Chiron is looking for essential enzymes or proteins that play a key role in the replication cycle of the virus. These virus-specific proteins could then be used as targets for drug discovery.
Because Hyseq will look a little silly inside of the second
tier letter C basket, I'll leave it out...however if fits very
nicely into Mike's Microcap Madness, and I have repurchased
it near $4 in the real world. |
